Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gwen S Scott

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Neurotrauma|September 30, 2004
Poly(ADP-ribose) polymerase activity contributes to peroxynitrite-induced spinal cord neuronal cell death in vitroGwen S Scott, Csaba Szabó, D Craig Hooper
Glia|January 2, 2003
Peroxynitrite-induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activationGwen S Scott, Laszlo Virág, Csaba Szabó, et al.
European Journal of Pharmacology|November 4, 2008
The acute and chronic phases of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE) are ameliorated by the peroxynitrite decomposition catalyst, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinatoiron (III) chloride, (FeTPPS)Christopher Bolton, Gwen S Scott, Terence Smith, et al.
Cellular and Molecular Neurobiology|March 31, 2009
A comparative evaluation of the response to peroxynitrite by a brain endothelial cell line and control of the effects by drug targetingChristopher Bolton, Elizabeth G Wood, Gwen S Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2005
Uric acid protects against secondary damage after spinal cord injuryGwen S Scott, Salvatore Cuzzocrea, Tiziana Genovese, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2002
Inhibition of hypochlorous acid-induced cellular toxicity by nitriteMatthew Whiteman, D Craig Hooper, Gwen S Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2007
Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse modelsMarzena J Fabis, Gwen S Scott, Rhonda B Kean, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2002
Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursorsGwen S Scott, Sergei V Spitsin, Rhonda B Kean, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2003
Differential expression of growth factors at the cellular level in virus-infected brainMikhail Prosniak, Anna Zborek, Gwen S Scott, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 26, 2004
The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulationGwen S Scott, Rhonda B Kean, Tatiana Mikheeva, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Neurotrauma|September 30, 2004
Poly(ADP-ribose) polymerase activity contributes to peroxynitrite-induced spinal cord neuronal cell death in vitroGwen S Scott, Csaba Szabó, D Craig Hooper
Glia|January 2, 2003
Peroxynitrite-induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activationGwen S Scott, Laszlo Virág, Csaba Szabó, et al.
European Journal of Pharmacology|November 4, 2008
The acute and chronic phases of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE) are ameliorated by the peroxynitrite decomposition catalyst, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinatoiron (III) chloride, (FeTPPS)Christopher Bolton, Gwen S Scott, Terence Smith, et al.
Cellular and Molecular Neurobiology|March 31, 2009
A comparative evaluation of the response to peroxynitrite by a brain endothelial cell line and control of the effects by drug targetingChristopher Bolton, Elizabeth G Wood, Gwen S Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2005
Uric acid protects against secondary damage after spinal cord injuryGwen S Scott, Salvatore Cuzzocrea, Tiziana Genovese, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2002
Inhibition of hypochlorous acid-induced cellular toxicity by nitriteMatthew Whiteman, D Craig Hooper, Gwen S Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2007
Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse modelsMarzena J Fabis, Gwen S Scott, Rhonda B Kean, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2002
Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursorsGwen S Scott, Sergei V Spitsin, Rhonda B Kean, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2003
Differential expression of growth factors at the cellular level in virus-infected brainMikhail Prosniak, Anna Zborek, Gwen S Scott, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 26, 2004
The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulationGwen S Scott, Rhonda B Kean, Tatiana Mikheeva, et al.
Pageof 2